Portfolio > Case Study
SomaLogic
Revolutionizing life sciences and healthcare by understanding the human proteome. Company IPO-ed via SPAC in April 2021.
Our portfolio
View all →
We invest wherever opportunity lives
Our portfolio proudly extends beyond verticals and asset classes
